TXG:NSD-10X Genomics Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 22.3

Change

+1.05 (+4.94)%

Market Cap

N/A

Volume

0.96M

Analyst Target

USD 120.25
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
GEHC GE HealthCare Technologies Inc..

-0.52 (-0.56%)

USD 42.11B
TEM Tempus AI, Inc. Class A Common..

+2.72 (+5.53%)

USD 7.92B
HQY HealthEquity Inc

+1.08 (+1.39%)

USD 6.94B
RCM R1 RCM Inc

+0.02 (+0.14%)

USD 5.98B
GDRX Goodrx Holdings Inc

+0.01 (+0.15%)

USD 2.57B
BTSG BrightSpring Health Services, ..

-0.24 (-1.60%)

USD 2.53B
PRVA Privia Health Group Inc

+0.44 (+2.51%)

USD 2.32B
OMCL Omnicell Inc

-0.22 (-0.52%)

USD 2.05B
PINC Premier Inc

+0.72 (+3.76%)

USD 2.04B
CERT Certara Inc

+0.24 (+2.29%)

USD 1.75B

ETFs Containing TXG

ARKG:LSE ARK Genomic Revolution UC.. 4.10 % 0.00 %

+0.03 (+0.53%)

USD 3.09M
ARKG 4.08 % 0.75 %

N/A

N/A
ARCG:LSE ARK Genomic Revolution UC.. 4.04 % 0.00 %

+0.30 (+0.53%)

USD 3.03M
GOAU U.S. Global GO GOLD and P.. 3.90 % 0.60 %

+0.27 (+0.53%)

USD 0.11B
SGDM Sprott Gold Miners ETF 3.79 % 0.57 %

+0.13 (+0.53%)

USD 0.28B
FDTS First Trust Developed Mar.. 0.00 % 0.80 %

+1.11 (+0.53%)

USD 8.62M
PZC:CA 0.00 % 0.67 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -60.15% 18% F 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -60.15% 18% F 12% F
Trailing 12 Months  
Capital Gain -45.94% 42% F 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -45.94% 40% F 19% F
Trailing 5 Years  
Capital Gain -56.30% 40% F 24% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -56.30% 35% F 23% F
Average Annual (5 Year Horizon)  
Capital Gain 9.18% 75% C 65% D
Dividend Return 9.18% 73% C 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 78.20% 18% F 22% F
Risk Adjusted Return 11.74% 67% D+ 48% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.